TCL Archive DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money August 31, 1979
TCL Archive Facilities Survey Finrs $25 Million a Year for Five Years Needed From NCI By Year 1990 March 8, 1985
TCL Archive Gloom and Doom Meeting of docs Turns Hopeful When Patient Offers Health Reform Proposal February 5, 1993
TCL Archive Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker October 3, 2014
